Nothing Special   »   [go: up one dir, main page]

Matorras et al., 2001 - Google Patents

Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis

Matorras et al., 2001

View HTML
Document ID
18151805686160757474
Author
Matorras R
Rodrı́guez F
Pijoan J
Etxanojauregui A
Neyro J
Elorriaga M
Rodrı́guez-Escudero F
Publication year
Publication venue
Fertility and sterility

External Links

Snippet

Objective: To compare the prevalence of endometriosis and its different stages in infertile women and women not exposed to spermatozoa. Design: Prospective study. Setting: Artificial insemination donor program at a university hospital. Patient (s): One hundred fifty …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets

Similar Documents

Publication Publication Date Title
Arcoverde et al. Surgery for endometriosis improves major domains of quality of life: a systematic review and meta-analysis
Sheikh et al. Evaluation of compliance and outcomes of a management protocol for massive postpartum hemorrhage at a tertiary care hospital in Pakistan
Shigemi et al. Safety of laparoscopic surgery for benign diseases during pregnancy: a nationwide retrospective cohort study
Matorras et al. Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis
Abbott et al. A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding
Amir et al. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women
Matteson et al. Menstrual health as a part of preventive health care
Comptour et al. Patient quality of life and symptoms after surgical treatment for endometriosis
Narayan et al. Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison
Cui et al. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study
Mendoza et al. Position of the Spanish Menopause Society regarding the management of perimenopause
Matorras et al. Endometriosis and spontaneous abortion rate: a cohort study in infertile women
Alborzi et al. Surgical outcomes of laparoscopic endometriosis surgery: a 6 year experience
Zhao et al. Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients
Gilbert et al. Direct methotrexate injection into the gestational sac for nontubal ectopic pregnancy: a review of efficacy and outcomes from a single institution
Munro et al. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process
Kim et al. The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization
Gunes et al. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study
Naessen et al. Endometrial thickness and uterine diameter not affected by ultralow doses of 17β-estradiol in elderly women
Yu et al. Clinical and patient reported outcomes of pre-and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy
Hatırnaz et al. Vaginal ultrasound-guided ovarian needle puncture compared to laparoscopic ovarian drilling in women with polycystic ovary syndrome
Woo et al. Loop Electrosurgical Excision Procedure: Safety and Tolerability Among Human Immunodeficiency Virus–Positive Kenyan Women
Bansal et al. Diagnosing the acutely locked knee
Mariani et al. Estradiol/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis
Fox Management of heavy menstrual bleeding in general practice